LENS - Presbia PLC

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
1.0900
+0.0600 (+5.83%)
As of 2:00PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close1.0500
Open1.0600
Bid1.0700 x 1400
Ask1.1000 x 1800
Day's Range0.9302 - 1.3570
52 Week Range0.2830 - 5.5000
Volume360,895
Avg. Volume178,051
Market Cap18.701M
Beta (3Y Monthly)4.14
PE Ratio (TTM)N/A
EPS (TTM)-0.5660
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est10.00
Trade prices are not sourced from all markets
  • Business Wire2 months ago

    Presbia Achieves ISO Medical Device Quality Milestone

    Presbia PLC (LENS), an ophthalmic device company and leader in near-vision restoration, achieved a major milestone towards complying with the revised ISO (International Standards Organization) 13485:2016 by successfully completing the ISO 13485:2016 audit with no major findings. This was an essential step in recertifying under the ISO standard with annual surveillance audits for the next two years. Notified Body NSAI (National Standards Authority of Ireland) conducted the audit.

  • Business Wire6 months ago

    Presbia to Participate in the XXXVI Congress of the European Society of Cataract & Refractive Surgeons and in the German Ophthalmological Society Congress

    Presbia PLC (LENS), an ophthalmic device company and leader in near-vision restoration, will participate in the XXXVI Congress of the European Society of Cataract and Refractive Surgeons (ESCRS), Europe's leading organization for cataract and refractive surgeons, to be held in Vienna, Austria from September 22-26, 2018. Mr. Yung will be available for one-on-one meetings at booth number B200 during the ESCRS. Presbia will also participate in the German Ophthalmological Society Congress to be held in Bonn, Germany from September 27-29, 2018.

  • We're sorry this is all we were able to find about this topic.